The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients

Clinica Chimica Acta

Volumn 389, Issue 1-2, 2008, Pages 61-66

  Mroczko, Barbara ^a   Kozłowski, Mirosław ^a   Groblewska, Magdalena ^a   Łukaszewicz, Marta ^a   Nikliński, Jacek ^a   Jelski, Wojciech ^a   Laudański, Jerzy ^a   Chyczewski, Lech ^a   Szmitkowski, Maciej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Esophageal cancer; Matrix metalloproteinases; Tumor markers

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GELATINASE B; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ESOPHAGUS CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

AGED; ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 38649106775     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.11.023     Document Type: Article

References (21)

1. Murray G.I., Duncan M.E., O'Neil P., et al. Matrix metalloproteinase-1 is associated with poor prognosis in esophageal cancer. J Pathol 185 (1998) 256-261
2. Crew K.D., and Neugut A. Epidemiology of upper gastrointestinal malignancies. Semin Oncol 31 (2004) 450-464
3. Pohn H., and Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97 (2005) 142-146
4. El-Shahat M., Lotfy M., Fahmy L., et al. Prognostic value of microvessel density, matrix metalloproteinase-9 and p53 protein expression in esophageal cancer. J Egypt Natl Cancer Inst 16 (2004) 224-230
5. Vallbohmer D., and Lenz H.J. Predictive and prognostic molecular markers in outcome of esophageal cancer. Dis Esophagus 19 (2006) 425-432
6. Samantaray S., Sharma R., Chattopadhyaya T.K., et al. Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 130 (2004) 37-44
7. Gu Z.D., Li J.Y., Li M., et al. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma. Am J Gastroenterol 100 (2005) 1835-1843
8. Vihinen P., and Kahari V.M. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer 99 (2002) 157-166
9. Nabeshima K., Inoue T., Shimao Y., et al. Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol International 52 (2002) 255-264
10. Gu Z.D., Chen K.N., Li M., et al. Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma. World J Gastroenterol 11 (2005) 871-874
11. Chen W., Abnet C.C., Wei W.Q., et al. Serum markers as predictors of esophageal squamous dysplasia and early cancer. Anticancer Res 24 (2004) 3245-3249
12. Sobin L.H., and Wittenkind C. International Union Against Cancer (UICC) TNM classification of malignant tumours. 5th edition (1997), Willey-Liss, New York
13. Oka M., Yamamoto K., Takahashi M., et al. Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res 56 (1996) 2776-2780
14. Mroczko B., Szmitkowski M., and Okulczyk B. Granulocyte-colony stimulating factor (G-CSF) and macrophage-colony stimulating factor (M-CSF) in colorectal cancer patients. Clin Chem Lab Med 40 (2002) 351-355
15. Fisher L.D., and van Belle G. Biostatististics: a methodology for the health science (1993), John Wiley and Sons, New York
16. Brockmann J.G., St Nottberg H., Glodny B., Heinecke A., and Senninger N.J. CYFRA 21-1 serum analysis in patients with esophageal cancer. Clin Cancer Res 6 (2000) 4249-4252
17. Shimada H., Nabeya Y., Tagawa M., et al. Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma. Cancer Sci 94 (2003) 628-632
18. Tanioka Y., Yoshida T., Yagawa T., et al. Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer. Br J Cancer 89 (2003) 2116-2121
19. Zucker S., Lysik R.M., Zarrabi M.H., et al. M(r) 92,000 type of collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 53 (1993) 140-146
20. Ylisirniö S., Höyhtyä M., and Turpeenniemi-Hujanen T. Serum matrix metalloproteinases-2,-9 and tissue inhibitors of metalloproteinases-1,-2 in lung cancer - TIMP-1 as a prognostic marker. Anticancer Res 20 (2000) 1311-1316
21. Polette M., Nawrocki-Raby B., Gilles C., et al. Tumor invasion and matrix metalloproteinase. Crit Rev Oncol Hematol 49 (2004) 179-186